Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.5694/j.1326-5377.1957.tb58084.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
INPATIENT REHABILITATION FOR A PATIENT WITH COVID-19 EXACERBATION OF PULMONARY FIBROSIS: A CASE REPORT.
J Rehabil Med Clin Commun
March 2025
James A. Eddy Research Institute, Sunnyview Rehabilitation Hospital. Schenectady, NY, USA.
Objective: To evaluate the benefits of inpatient rehabilitation for a patient with post-COVID-19 pulmonary fibrosis and to provide guidance for rehabilitation professionals, as many conventional therapeutic interventions are not tolerated and are poorly defined.
Design: A case report.
Subjects/patients: A 72-year-old man with a COVID-19-related idiopathic pulmonary fibrosis exacerbation.
Efficacy and safety of pleurodesis for lung cancer patients with interstitial lung disease.
J Thorac Dis
February 2025
Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
Background: Managing malignant pleural effusion (MPE) with pleurodesis is essential for symptom relief and minimizing the need for repeated thoracentesis. Interstitial lung disease (ILD) is one of the most common complications associated with advanced lung cancer. However, the efficacy and safety of pleurodesis for MPE secondary to lung cancer with ILD remains unclear.
View Article and Find Full Text PDFKorean Guidelines for the Diagnosis and Management of Interstitial Lung Disease: Part 5-Other Forms of Interstitial Lung Disease.
Tuberc Respir Dis (Seoul)
March 2025
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Wonkwang University School of Medicine, Iksan, Republic of Korea.
Rare forms of interstitial lung diseases (ILDs) present with unique clinical features and require different treatment strategies. Respiratory bronchiolitis-associated ILD mainly affects smokers, showing ground-glass opacities on chest computed tomography (CT) scans and pigmented macrophages in the bronchoalveolar lavage fluid. Smoking cessation is essential for treatment, with corticosteroids used for severe cases.
View Article and Find Full Text PDFKorean Guidelines for Diagnosis and Management of Interstitial Lung Disease: Cryptogenic organizing pneumonia.
Tuberc Respir Dis (Seoul)
March 2025
Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Republic of Korea.
Cryptogenic organizing pneumonia (COP), one of the idiopathic interstitial pneumonias (IIP), exhibits an acute or subacute course. It can be diagnosed after excluding secondary causes or diseases. COP accounts for approximately 5-10% of IIPs, with the average age of diagnosis ranging from 50 to 60 years.
View Article and Find Full Text PDFSerum Soluble Toll-Like Receptor 4 is a Predictive Biomarker for Acute Exacerbation and Prognosis of Idiopathic Pulmonary Fibrosis: A Retrospective Study.
Lung
March 2025
Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Purpose: Toll-like receptor 4 (TLR4) is a transmembrane receptor promoting pro-inflammatory signalling, that is associated with the pathogenesis of pulmonary fibrosis. TLR4 is abundantly expressed on monocytes and the acceleration of TLR4 signalling induces the secretion of soluble TLR4 isoforms (sTLR4) in circulation. The aim of study was to evaluate the association of serum levels of sTLR4 with acute exacerbation (AE) and prognosis of patients with idiopathic pulmonary fibrosis (IPF).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!